Back to search

Article

A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction

2026-03-05

Abstract excerpt

<title>Abstract</title> <p>Background Cancer-related sarcopenia is associated with poor clinical outcomes but remains difficult to define and quantify in routine oncology practice. Current assessments rely on imaging and functional scales that are time-consuming and provide limited biological insight. We aimed to identify a plasma proteomic signature of cancer-related sarcopenia and to uncover circulating mediat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f714a4e-bf55-5bdc-a920-35832f617b00
DOI
10.21203/rs.3.rs-8885139/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunctionDOI 10.21203/rs.3.rs-8885139/v1
A Novel Prognostic Scoring System Based on F-18 FDG PET/CT Volumetric Parameters, Sarcopenia, and Clinical Variables in Patients Receiving Immunotherapy for Advanced Solid Tumors: The Immunotherapy Prognostic Score (IPS)Semantic proximity
Development and Validation of a Clinically Useful Nomogram for Predicting Sarcopenia in Bone Tumor PatientsSemantic proximity
Host-Derived Immunometabolic Biomarkers Identify Prognostic Profiles under Immunotherapy in Advanced NSCLC: the SARC-LUNG StudySemantic proximity
Proteomics signature of physical activity and risk of multimorbidity of cancer and cardiometabolic diseasesSemantic proximity
Characterization of pretreatment cachexia through cytokine and nutritional analysis in lung cancer: the Marató cohortSemantic proximity
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity
Plasma proteomics identifies an IL-6–associated SAA axis linked to muscle wasting in patients with cancer cachexiaSemantic proximity
Tumor Transcriptome in Patients with Lower Pectoralis Muscle Area Reveals IL-8 as a Prognostic Biomarker in Non-Small Cell Lung CancerSemantic proximity
Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast Cancer.Semantic proximity
Molecular & Translational Biology of the Blood-Based VeriStrat® Proteomic Test Used in Cancer Immunotherapy Treatment GuidanceSemantic proximity
Anatomical dynamics define cancer cachexia subtypes and identify systemic inflammation as a marker of lethal wastingSemantic proximity
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients.Semantic proximity
Select a neighboring publication to make it the new centre.